Kymera Therapeutics, Inc. Common Stock (KYMR) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for KYMR. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 266 institutions reported holding KYMR, with 97.0 million shares worth $11.1 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| T. Rowe Price | 13,370,241 | $1.5B | INCREASED |
| FMR | 12,349,256 | $1.4B | INCREASED |
| Baker Bros. Advisors | 8,657,242 | $993M | UNCHANGED |
| Avoro Capital Advisors | 7,474,747 | $857M | UNCHANGED |
| Vanguard | 6,467,324 | $742M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Nello Mainolfi (Chief Executive Officer) | EXERCISE | 30,000 | $62K | 2026-10-01 |
| Nello Mainolfi (Chief Executive Officer) | SELL | 262 | $30K | 2026-10-01 |
| Nello Mainolfi (Chief Executive Officer) | SELL | 8,230 | $950K | 2026-10-01 |
| Nello Mainolfi (Chief Executive Officer) | SELL | 7,601 | $870K | 2026-10-01 |
| Nello Mainolfi (Chief Executive Officer) | SELL | 4,876 | $552K | 2026-10-01 |
Full institutional holdings, insider history, and congressional trades for Kymera Therapeutics, Inc. Common Stock on SentiSense.